Accendra Health Inc(ACH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -3.92 | Insider Own | 9.79% | Shs Outstand | 76.9M | Perf Week | 10.53% |
| Market Cap | 0.02B | Forward P/E | 2.12 | EPS next Y | 3201.74% | Insider Trans | - | Shs Float | 69.4M | Perf Month | -58.59% |
| Enterprise Value | 1.83B | PEG | - | EPS next Q | 0.01 | Inst Own | 91.67% | Short Float | 13.13% | Perf Quarter | -92.46% |
| Income | -0.30B | P/S | 0.01 | EPS this Y | -99.67% | Inst Trans | 16.53% | Short Ratio | 4.97 | Perf Half Y | -93.72% |
| Sales | 2.65B | P/B | - | EPS next 5Y | - | ROA | -3.53% | Short Interest | 9.11M | Perf YTD | -91.68% |
| Book/sh | -7.16 | P/C | 2.34 | EPS past 3/5Y | - | ROE | -198.35% | 52W High | -95.67% ($5.38) | Perf Year | -95.54% |
| Cash/sh | 0.1 | P/FCF | - | Sales past 3/5Y | -34.78% -20.1% | ROIC | -24.56% | 52W Low | 21.99% ($0.19) | Perf 3Y | -98.32% |
| Dividend Est. | - | EV/EBITDA | 6.27 | EPS Y/Y TTM | 74.88% | Gross Margin | 39.89% | Volatility(W/M) | 13.37% 16.65% | Perf 5Y | -99.35% |
| Dividend TTM | - | EV/Sales | 0.69 | Sales Y/Y TTM | -69.68% | Oper. Margin | 1.35% | ATR (14) | 0.06 | Perf 10Y | -99.28% |
| Dividend Ex-Date | 2022/6/30 | Quick Ratio | 0.3 | EPS Q/Q | 89.72% | Profit Margin | -11.41% | RSI (14) | 21.79 | Recom | 3.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.41 | Sales Q/Q | -10.07% | SMA20 | -25.75% ($0.31) | Beta | 1.51 | Target Price | $1.25 |
| Payout | - | Debt/Eq | - | Earnings | 2026/11/5 | SMA50 | -68.13% ($0.72) | Rel Volume | 0.99 | Prev Close | $0.23 |
| Employees | 6500 | LT Debt/Eq | - | EPS/Sales Surpr. | -126.73% -2.46% | SMA200 | -89.64% ($2.22) | Avg Volume(3M) | 1.83M | Price | $0.23 |
| IPO | 1982/11/1 | Option/Short | Yes/Yes | Trades | 2309 | Volume | 1,821,919 | Change | - |
Accendira Health (ACH) is a US-based home healthcare company serving patients across the country. The company supplies a portfolio of essential medical products for home use, including diabetes care, sleep health, wound care, respiratory, and urology products. With its Apria and Byram brands, Accendira Health is focused on the home medical market.
Over the past 1 year, on the lower side
96% below its 1-year high.
Traded about as much as usual. That is 99% of its average volume.
Next earnings report: November 5
6 days to go.
ACH keeps an operating profit but posts a net loss
Of every $100 in sales, $1.35 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by -99.7% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $1. Peers typically go for $283. Compared with its own 1-year average, it is 233% pricier now.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -99.3%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 91.7%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
APPC Corgi APP 2x Daily ETF 0.01% 
BTR Beacon Tactical Risk ETF <0.01% 
FFLS The Future Fund Long/Short ETF <0.01% 
MYHD State Street My2030 High Yield Corporate Bond ETF <0.01% 
MYHC State Street My2029 High Yield Corporate Bond ETF <0.01% Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
QTUM Defiance Quantum ETF 5.4B 
FAI First Trust Bloomberg Artificial Intelligence ETF 267M 
XAIX Xtrackers Artificial Intelligence and Big Data ETF 160M 
QTUP Defiance Pure Quantum ETF 18M 
XA Corgi AI Cybersecurity ETF 8M It ranks #8 of 10 in the industry
Based on market cap of $18M.
FOCL#6 EDAP TMS SA ADR $156M PER - 
COSM#7 Cosmos Health Inc $28M PER - ACH#8 Accendra Health Inc $18M PER - 
YI#9 111 Inc ADR $15M PER - 
MEDS#10 DataMEDS AI Inc $9M PER - 
FAQ
What kind of company is ACH?
ACH belongs to the Healthcare sector and operates in the Medical Distribution industry.
What is the market cap of ACH?
The market cap of ACH is approximately $18M, ranking 5,248 within its sector.
What is the 52-week high and low for ACH?
ACH has recorded a 52-week high of $5.38 and a low of $0.19.
